Stock 1099 SINOPHARM GROUP CO. LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Sinopharm Group Co. Ltd.

Equities

1099

CNE100000FN7

Market Closed - Hong Kong S.E.
Other stock markets
 01:38:20 26/04/2024 pm IST 		5-day change 1st Jan Change
21.55 HKD -0.92% Intraday chart for Sinopharm Group Co. Ltd. +8.40% +5.38%
26/04 Central Bank, Tech Outlooks Lift Major Asian Stock Markets MT
16/04 Shyndec Pharmaceutical's Unit Gets Nod to Market Empagliflozin Tablets MT

Chart calendar Sinopharm Group Co. Ltd.

f3deaf.JRv4YHsOgvqEAMGDAjOX02rTH5h2gAdoJCcMvA9n5SM.f3yaUDM2zpHddLDLUACuoj6RZd4S7zY-SH5p72Qtt0gSV7pWC2T4kt1wsg~46dfa950b98eb0d5e9aab4c3cc1e2cfb

Upcoming events on Sinopharm Group Co. Ltd.

13/06/2024 Annual General Meeting
17/06/2024 Ex-dividend day for final dividend
26/08/2024 Q2 2024 Earnings Release (Projected)
28/10/2024 Q3 2024 Earnings Release (Projected)
21/03/2025 Q4 2024 Earnings Release (Projected)

Past events on Sinopharm Group Co. Ltd.

26/04/2024 Q1 2024 Earnings Release
25/03/2024 Q4 2023 Earnings Release
30/10/2023 Q3 2023 Earnings Release
15/09/2023 06:30 am Extraordinary Shareholders Meeting
25/08/2023 Q2 2023 Earnings Release
19/06/2023 Ex-dividend day for final dividend
27/04/2023 Q1 2023 Earnings Release
24/03/2023 Q4 2022 Earnings Release
26/10/2022 Q3 2022 Earnings Release
29/08/2022 Interim 2022 Earnings Release
27/06/2022 Ex-dividend day for final dividend
21/04/2022 Q1 2022 Earnings Release
18/03/2022 FY 2021 Earnings Release
22/10/2021 Q3 2021 Earnings Release
23/08/2021 Interim 2021 Earnings Release
15/06/2021 Ex-dividend day for final dividend
27/04/2021 Q1 2021 Earnings Release
22/03/2021 FY 2020 Earnings Release
24/08/2020 Interim 2020 Earnings Release
15/06/2020 Ex-dividend day for final dividend

Past dividends on Sinopharm Group Co. Ltd.

19/06/2023 Annual 0.9 HKD
27/06/2022 Annual 0.872 HKD
15/06/2021 Annual 0.839416 HKD
15/06/2020 Annual 0.6521739 HKD
02/07/2019 Annual 0.6712172 HKD
04/07/2018 Annual 0.6867469 HKD
04/07/2017 Annual 0.5720823 HKD
21/06/2016 Annual 0.4823529 HKD
25/06/2015 Annual 0.3924 HKD
24/06/2014 Annual 0.3275549 HKD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million CNY		Released
Forecast
Spread 		425 273
410 503
3.6%		456 415
459 286
-0.63%		521 051
524 915
-0.74%		552 148
567 081
-2.63%		596 570
607 023
-1.72%
651 835

EBITDA
Million CNY		Released
Forecast
Spread 		17 950
18 933
-5.19%		19 667
20 169
-2.49%		23 634
23 048
2.54%		24 769
24 143
2.59%		24 639
25 847
-4.67%
26 669

EBIT
Million CNY		Released
Forecast
Spread 		16 137
17 429
-7.42%		17 760
18 523
-4.12%		19 712
20 714
-4.84%		20 604
21 448
-3.93%		20 209
22 853
-11.57%
23 514

Earnings before Tax (EBT)
Million CNY		Released
Forecast
Spread 		13 760
13 685
0.55%		15 598
14 911
4.61%		17 003
17 731
-4.11%		18 564
18 332
1.26%		19 512
19 766
-1.29%
21 350

Net income
Million CNY		Released
Forecast
Spread 		6 253
6 418
-2.58%		7 187
6 851
4.9%		7 759
8 025
-3.31%		8 526
8 328
2.37%		9 054
8 884
1.91%
9 827

EPS
CNY		Released
Forecast
Spread 		2,10
2,14
-2.02%		2,31
2,24
3.17%		2,49
2,57
-3.13%		2,73
2,67
2.26%		2,90
2,85
1.89%
3,15

Announcement Date30/03/2021/03/2120/03/2226/03/2324/03/24-

Quarterly results

Fiscal PeriodDecember 2019 S2 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2023 S2 2024 S1
Net sales
Million CNY		Released
Forecast
Spread 		223 608
225 972
-1.05%		203 765
214 953
-5.21%		252 650
252 038
0.24%		249 120
249 785
-0.27%		271 931
272 843
-0.33%		261 472
267 971
-2.43%		290 676
295 237
-1.54%		18 687


155 433
144 735
7.39%		300 950
295 098
1.98%		144 969
152 155
-4.72%		150 650
150 446
0.14%		295 619
313 454
-5.69%
321 924

EBIT
Million CNY		Released
Forecast
Spread








8 772
9 109
-3.7%		10 940
12 518
-12.6%		9 057
9 669
-6.33%		11 547
12 026
-3.98%


5 895
5 765
2.26%		10 869
10 855
0.13%		5 937
6 086
-2.45%		4 691
5 664
-17.18%		10 628
13 044
-18.52%
11 691

Earnings before Tax (EBT)
Million CNY		Released
Forecast
Spread























5 228
5 052
3.49%		8 866
8 689
2.04%		4 161
4 945
-15.86%		6 485
5 927
9.42%





Net income
Million CNY		Released
Forecast
Spread




















362


2 514
2 399
4.8%		4 104
3 989
2.89%		1 752
2 247
-22.01%








Announcement Date30/03/2023/08/2021/03/2122/08/2120/03/2229/08/2226/03/2317/04/2327/08/2327/08/2330/10/2324/03/2424/03/24-

Upcoming sector events for Sinopharm Group Co. Ltd.

29/04/2024 CACHET PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 CACHET PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
30/04/2024 SHENZHEN NEPTUNUS BIOENGINEERING CO., LTD.: Q1 2024 Earnings Release
30/04/2024 SHENZHEN NEPTUNUS BIOENGINEERING CO., LTD.: Q4 2023 Earnings Release
30/04/2024 REALCAN PHARMACEUTICAL GROUP CO., LTD.: Q1 2024 Earnings Release
30/04/2024 CHINA NATIONAL ACCORD MEDICINES CORPORATION LTD.: Q1 2024 Earnings Release
30/04/2024 CHINA MEHECO GROUP CO., LTD.: Q1 2024 Earnings Release
30/04/2024 NANJING PHARMACEUTICAL COMPANY LIMITED: Q1 2024 Earnings Release
30/04/2024 REALCAN PHARMACEUTICAL GROUP CO., LTD.: Q4 2023 Earnings Release
02/05/2024 CARDINAL HEALTH, INC.: Q3 2024 Earnings Release
More events

Past sector events for Sinopharm Group Co. Ltd.

27/04/2024 C.Q. PHARMACEUTICAL HOLDING CO., LTD.: Q4 2023 Earnings Release
27/04/2024 C.Q. PHARMACEUTICAL HOLDING CO., LTD.: Q1 2024 Earnings Release
27/04/2024 ZHEJIANG INT'L GROUP CO.,LTD.: Q1 2024 Earnings Release
27/04/2024 JOINTOWN PHARMACEUTICAL GROUP CO., LTD: Q1 2024 Earnings Release
27/04/2024 JOINTOWN PHARMACEUTICAL GROUP CO., LTD: Q4 2023 Earnings Release
27/04/2024 CHINA MEHECO GROUP CO., LTD.: Q4 2023 Earnings Release
26/04/2024 SINOPHARM GROUP CO. LTD.: Q1 2024 Earnings Release
26/04/2024 GUANGXI LIUYAO GROUP CO., LTD: Q1 2024 Earnings Release
26/04/2024 GUANGXI LIUYAO GROUP CO., LTD: Q4 2023 Earnings Release
26/04/2024 HUADONG MEDICINE CO., LTD: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 1099 Stock
  4. Calendar Sinopharm Group Co. Ltd.